Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis

BackgroundHyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patient...

Full description

Bibliographic Details
Main Authors: Abdul Hakim Alkatiri, Nurul Qalby, Idar Mappangara, Ahmad Taufik F. Zainal, Maarten J. Cramer, Pieter A. Doevendans, Andriany Qanitha
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1303685/full
_version_ 1797266400714162176
author Abdul Hakim Alkatiri
Abdul Hakim Alkatiri
Nurul Qalby
Nurul Qalby
Idar Mappangara
Idar Mappangara
Ahmad Taufik F. Zainal
Maarten J. Cramer
Pieter A. Doevendans
Pieter A. Doevendans
Andriany Qanitha
Andriany Qanitha
Andriany Qanitha
author_facet Abdul Hakim Alkatiri
Abdul Hakim Alkatiri
Nurul Qalby
Nurul Qalby
Idar Mappangara
Idar Mappangara
Ahmad Taufik F. Zainal
Maarten J. Cramer
Pieter A. Doevendans
Pieter A. Doevendans
Andriany Qanitha
Andriany Qanitha
Andriany Qanitha
author_sort Abdul Hakim Alkatiri
collection DOAJ
description BackgroundHyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. We aimed to compile evidence to assess the association between hyperglycemia and adverse outcomes.MethodsWe conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles. After full-text screening, 66 articles were included for systematic review, and 62 articles were further selected for meta-analysis.ResultsThe 66 included articles spanned the years 2005–2023. Of these, 45 articles reported admission blood glucose, 13 articles used HbA1c, and 7 articles studied fasting blood glucose. Most studies defined STEMI with primary PCI as their inclusion criteria. Mortality was the most often outcome reported related to hyperglycemia. Overall, 55 (83.3%) studies were at low risk of bias. Both admission and fasting blood glucose were significantly related to short- and long-term mortality after STEMI, with a pooled risk ratio (RR) of 3.02 (95%CI: 2.65–3.45) and 4.47 (95% CI: 2.54–7.87), respectively. HbA1c showed substantial association with long-term mortality (HR 1.69, 95% CI: 1.31–2.18)) with a pooled RR of 1.58 (95% CI 1.26–1.97). In subsequent analyses, admission hyperglycemia was associated with an increased risk of reinfarction (pooled RR 1.69, 95% CI 1.31–2.17), heart failure (pooled RR 1.56, 95% CI: 1.37–1.77), cardiogenic shock (pooled RR 3.68, 95% CI 2.65–5.11), repeat PCI or stent thrombosis (pooled RR 1.99, 95% CI 1.21–3.28), and composite major adverse cardiac and cerebrovascular events (MACCE) (pooled RR 1.99, 95% CI: 1.54–2.58).ConclusionsOur study demonstrated that hyperglycemia has a strong association with poor outcomes after STEMI. Admission and fasting blood glucose are predictors for short-term outcomes, while HbA1c is more appropriate for predicting longer-term outcomes in STEMI patients.Systematic Review RegistrationPROSPERO 2021 (CRD42021292985).
first_indexed 2024-04-25T01:00:06Z
format Article
id doaj.art-0666a7ba796d4166aa256c58b54958da
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-25T01:00:06Z
publishDate 2024-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-0666a7ba796d4166aa256c58b54958da2024-03-11T05:03:51ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-03-011110.3389/fcvm.2024.13036851303685Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysisAbdul Hakim Alkatiri0Abdul Hakim Alkatiri1Nurul Qalby2Nurul Qalby3Idar Mappangara4Idar Mappangara5Ahmad Taufik F. Zainal6Maarten J. Cramer7Pieter A. Doevendans8Pieter A. Doevendans9Andriany Qanitha10Andriany Qanitha11Andriany Qanitha12Department of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaMakassar Cardiac Center, Dr. Wahidin Sudirohusodo General Teaching Hospital, Makassar, IndonesiaDepartment of Public Health and Community Medicine, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaHeart and Lung Division, Department of Cardiology, University Medical Center Utrecht, Utrecht, NetherlandsDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaMakassar Cardiac Center, Dr. Wahidin Sudirohusodo General Teaching Hospital, Makassar, IndonesiaFaculty of Medicine, Hasanuddin University, Makassar, IndonesiaHeart and Lung Division, Department of Cardiology, University Medical Center Utrecht, Utrecht, NetherlandsHeart and Lung Division, Department of Cardiology, University Medical Center Utrecht, Utrecht, NetherlandsNetherlands Heart Institute, Utrecht, NetherlandsDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaDepartment of Physiology, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaDoctoral Study Program, Faculty of Medicine, Hasanuddin University, Makassar, IndonesiaBackgroundHyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). There are conflicting sources regarding the relationship between hyperglycemia and outcomes in STEMI patients. We aimed to compile evidence to assess the association between hyperglycemia and adverse outcomes.MethodsWe conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles. After full-text screening, 66 articles were included for systematic review, and 62 articles were further selected for meta-analysis.ResultsThe 66 included articles spanned the years 2005–2023. Of these, 45 articles reported admission blood glucose, 13 articles used HbA1c, and 7 articles studied fasting blood glucose. Most studies defined STEMI with primary PCI as their inclusion criteria. Mortality was the most often outcome reported related to hyperglycemia. Overall, 55 (83.3%) studies were at low risk of bias. Both admission and fasting blood glucose were significantly related to short- and long-term mortality after STEMI, with a pooled risk ratio (RR) of 3.02 (95%CI: 2.65–3.45) and 4.47 (95% CI: 2.54–7.87), respectively. HbA1c showed substantial association with long-term mortality (HR 1.69, 95% CI: 1.31–2.18)) with a pooled RR of 1.58 (95% CI 1.26–1.97). In subsequent analyses, admission hyperglycemia was associated with an increased risk of reinfarction (pooled RR 1.69, 95% CI 1.31–2.17), heart failure (pooled RR 1.56, 95% CI: 1.37–1.77), cardiogenic shock (pooled RR 3.68, 95% CI 2.65–5.11), repeat PCI or stent thrombosis (pooled RR 1.99, 95% CI 1.21–3.28), and composite major adverse cardiac and cerebrovascular events (MACCE) (pooled RR 1.99, 95% CI: 1.54–2.58).ConclusionsOur study demonstrated that hyperglycemia has a strong association with poor outcomes after STEMI. Admission and fasting blood glucose are predictors for short-term outcomes, while HbA1c is more appropriate for predicting longer-term outcomes in STEMI patients.Systematic Review RegistrationPROSPERO 2021 (CRD42021292985).https://www.frontiersin.org/articles/10.3389/fcvm.2024.1303685/fulladverse outcomeshyperglycemiaMACCEmortalitySTEMIrevascularization
spellingShingle Abdul Hakim Alkatiri
Abdul Hakim Alkatiri
Nurul Qalby
Nurul Qalby
Idar Mappangara
Idar Mappangara
Ahmad Taufik F. Zainal
Maarten J. Cramer
Pieter A. Doevendans
Pieter A. Doevendans
Andriany Qanitha
Andriany Qanitha
Andriany Qanitha
Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine
adverse outcomes
hyperglycemia
MACCE
mortality
STEMI
revascularization
title Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
title_full Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
title_fullStr Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
title_full_unstemmed Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
title_short Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis
title_sort stress hyperglycemia and poor outcomes in patients with st elevation myocardial infarction a systematic review and meta analysis
topic adverse outcomes
hyperglycemia
MACCE
mortality
STEMI
revascularization
url https://www.frontiersin.org/articles/10.3389/fcvm.2024.1303685/full
work_keys_str_mv AT abdulhakimalkatiri stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT abdulhakimalkatiri stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT nurulqalby stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT nurulqalby stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT idarmappangara stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT idarmappangara stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT ahmadtaufikfzainal stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT maartenjcramer stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT pieteradoevendans stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT pieteradoevendans stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT andrianyqanitha stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT andrianyqanitha stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis
AT andrianyqanitha stresshyperglycemiaandpooroutcomesinpatientswithstelevationmyocardialinfarctionasystematicreviewandmetaanalysis